Adagio Medical (ADGM) Financials: Revenue & Earnings
ADGM$0.10-0.00 -4.10%
$2.63M
Market Cap
—
P/E
—
Forward P/E
—
Score
Adagio Medical (ADGM) Financials: Revenue & Earnings
ADGM price $0.10 -0.00 -4.10%
- Ticker
- ADGM
- Price
- $0.10
- Change
- -0.00 -4.10%
- Market cap ?
- $2.63M
- Beta ?
- -0.19
- Sector
- Healthcare
- Industry
- Medical - Devices
Fair value
ADGM fair value Not meaningful. Price $0.10.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Not meaningful
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-11 | — | -0.25 | — | — |
| 2026-08-11 | -0.30 | -0.27 | — | — |
| 2026-05-12 | -0.31 | -0.36 | — | — |
| 2026-03-27 | -0.21 | -0.31 | — | — |
| 2025-11-12 | -0.66 | -0.43 | — | — |
| 2025-08-13 | -0.35 | — | — | — |
| 2025-05-15 | -0.50 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-16 | Salmon Sean | Buy | 30.00K | $0.71 | 21.31K |
| 2026-06-16 | Mirsaeedi-Farahani Keyvan | Buy | 30.00K | $0.71 | 21.31K |
| 2026-06-16 | Cox James L | Buy | 30.00K | $0.71 | 21.31K |
| 2026-06-16 | GARDINER SANDRA A. | Buy | 30.00K | $0.71 | 21.31K |
| 2026-06-16 | MISHAN ORLY | Buy | 100.00K | $0.71 | 71.03K |
| 2026-06-16 | Moran Timothy P. | Buy | 30.00K | $0.71 | 21.31K |
| 2026-03-06 | Kaster Deborah | Buy | 490.50K | $0.98 | 479.22K |
| 2026-03-06 | Usen Todd | Buy | 800.00K | $0.98 | 781.60K |
| 2025-12-16 | Kaster Deborah | Buy | 15.00K | $1.20 | 17.97K |
| 2025-12-12 | Usen Todd | Buy | 207.31K | $1.09 | 225.97K |
| 2025-12-11 | Salmon Sean | Buy | 90.00K | $0.88 | 79.01K |
| 2025-12-11 | Salmon Sean | Other | 0 | — | — |
| 2025-10-20 | PERCEPTIVE ADVISORS LLC | Buy | 2.19M | $0.00 | 219 |
| 2025-10-20 | PERCEPTIVE ADVISORS LLC | Buy | 1.34M | $1.71 | 2.30M |
| 2025-10-20 | PERCEPTIVE ADVISORS LLC | Buy | 1.34M | $1.71 | 2.30M |
| 2025-10-20 | PERCEPTIVE ADVISORS LLC | Buy | 1.34M | $1.71 | 2.30M |
| 2025-09-05 | Kaster Deborah | Other | 728.00K | $0.84 | 611.52K |
| 2025-04-17 | George Dan | Other | 0 | — | — |
| 2025-03-20 | Cox James L | Buy | 364.00K | $0.86 | 314.86K |
| 2025-03-20 | Cox James L | Buy | 90.00K | $0.86 | 77.85K |
| 2025-03-20 | GARDINER SANDRA A. | Buy | 90.00K | $0.86 | 77.85K |
| 2025-03-20 | Mirsaeedi-Farahani Keyvan | Buy | 90.00K | $0.86 | 77.85K |
| 2025-03-20 | MISHAN ORLY | Buy | 300.00K | $0.86 | 259.50K |
| 2025-03-20 | Moran Timothy P. | Buy | 90.00K | $0.86 | 77.85K |
| 2025-02-11 | Usen Todd | Buy | 1.82M | $1.13 | 2.06M |
| 2025-01-22 | PERCEPTIVE ADVISORS LLC | Buy | 64.17K | $2.00 | 128.33K |
| 2024-12-13 | Usen Todd | Other | 0 | — | — |
| 2024-09-27 | Mirsaeedi-Farahani Keyvan | Buy | 12.77K | — | — |
| 2024-09-27 | ARYA Sciences Holdings IV | Sell | 3.50M | $0.00 | 350 |
| 2024-07-31 | BERGHEIM OLAV | Buy | 212.05K | — | — |
| 2024-07-31 | BERGHEIM OLAV | Buy | 22.08K | — | — |
| 2024-07-31 | Bergheim Hakon | Buy | 7.54K | — | — |
| 2024-07-31 | Bergheim Hakon | Buy | 1.00K | $9.78 | 9.78K |
| 2024-07-31 | Cox James L | Buy | 36.70K | — | — |
| 2024-07-31 | PERCEPTIVE ADVISORS LLC | Other | 0 | — | — |
| 2024-07-31 | PERCEPTIVE ADVISORS LLC | Other | 5.45M | $10.00 | 54.45M |
| 2024-07-31 | PERCEPTIVE ADVISORS LLC | Other | 525.00K | $24.00 | 12.60M |
| 2024-07-31 | PERCEPTIVE ADVISORS LLC | Other | 700.00K | — | — |
| 2024-07-31 | ARYA Sciences Holdings IV | Other | 0 | — | — |
| 2024-07-31 | GARDINER SANDRA A. | Other | 0 | — | — |
| 2024-07-31 | MISHAN ORLY | Other | 0 | — | — |
| 2024-07-31 | Moaddeb Shahram | Other | 0 | — | — |
| 2024-07-31 | Moran Timothy P. | Other | 0 | — | — |
| 2024-07-31 | Mirsaeedi-Farahani Keyvan | Other | 0 | — | — |
| 2024-07-31 | Cox James L | Other | 0 | — | — |
| 2024-07-31 | Dahldorf John T | Other | 0 | — | — |
| 2024-07-31 | Bergheim Hakon | Other | 0 | — | — |
| 2024-07-31 | BERGHEIM OLAV | Other | 0 | — | — |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 24, holders +1 vs prior quarter. Ownership 67.86%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 9.88M | 10 | +0.00% | 6.44M |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.26M | 0 | 0.00% | 820.04K |
| ADAR1 CAPITAL MANAGEMENT, LLC | 1.21M | 0 | 0.00% | 785.47K |
| ALYESKA INVESTMENT GROUP, L.P. | 1.16M | 0 | 0.00% | 755.61K |
| SIO CAPITAL MANAGEMENT, LLC | 698.99K | -589.47K | -45.75% | 455.46K |
| SILVERARC CAPITAL MANAGEMENT, LLC | 224.36K | -27.61K | -10.96% | 146.19K |
| SHAOLIN CAPITAL MANAGEMENT LLC | 171.17K | 0 | 0.00% | 111.53K |
| VANGUARD CAPITAL MANAGEMENT LLC | 108.95K | 69.35K | +175.08% | 71.04K |
| AFFINITY ASSET ADVISORS, LLC | 80.00K | 0 | 0.00% | 52.13K |
| GEODE CAPITAL MANAGEMENT, LLC | 79.11K | -46.13K | -36.83% | 51.55K |
| VANGUARD FIDUCIARY TRUST CO | 53.78K | 0 | 0.00% | 35.07K |
| NORTHERN TRUST CORP | 30.88K | 9.28K | +42.95% | 20.12K |
| TORONTO DOMINION BANK | 25.00K | 0 | 0.00% | 16.30K |
| OPALEYE MANAGEMENT INC. | 18.44K | 0 | 0.00% | 13.35K |
| XTX TOPCO LTD | 18.15K | -5.20K | -22.26% | 11.83K |
| CITADEL ADVISORS LLC | 16.16K | 16.16K | New | 10.53K |
| CITIGROUP INC | 13.26K | 13.25K | +1325400.00% | 8.64K |
| HRT FINANCIAL LP | 13.71K | 13.71K | New | 8.00K |
| BANK OF AMERICA CORP /DE/ | 11.53K | -1.33K | -10.31% | 7.51K |
| TOWER RESEARCH CAPITAL LLC (TRC) | 6.45K | 4.25K | +193.10% | 4.21K |
| UBS GROUP AG | 2.27K | 2.27K | New | 1.48K |
| CREWE ADVISORS LLC | 500 | 0 | 0.00% | 326 |
| MORGAN STANLEY | 137 | 0 | 0.00% | 89 |
| BARCLAYS PLC | 23 | 23 | New | 15 |
| JPMORGAN CHASE & CO | 0 | -975 | -100.00% | 0 |
Earnings and financials
Adagio Medical Holdings, Inc. (ADGM) trades at $0.10, with a market cap of $2.63M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn